Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f0dfb8bfb612da81351f06a67b00bc1d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ce92f7796f33fc67be0c51ae031accd http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eeb56f6708963cf475ef35acd2d2cf3b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2878 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate |
2011-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb273c1cc212bde8e29f18e9b89d2960 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd6872909ec93b10edc952b6d397db9d |
publicationDate |
2013-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2013011407-A1 |
titleOfInvention |
Pharmaceutical composition for treatment or prevention of osteoarthritis, and method of production therefor |
abstract |
Pharmaceutical compositions for treating or preventing diseases classified as any of grade 1 to 3 according to the ICRS classification of osteoarthritis, classified as any of grade 1 to 3 according to the Kellgren-Lawrence classification of osteoarthritis or classified as any of grade 1 to 3 according to the Outerbridge classification of osteoarthritis and methods of manufacturing same contain anti-Fas IgM antibody as an active ingredient and a pharmaceutically acceptable carrier with acidity of pharmaceutical compositions ranging from pH 4 to pH 9 to alleviate osteoarthritis symptoms by inhibiting the production of cartilage matrix degrading enzymes and by increasing the production of cartilage matrix. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017150455-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9794889-B2 |
priorityDate |
2010-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |